Advanced Trauma Life Support (ATLS)

Introduction

Trauma is a leading cause of death, particularly in the first four decades of life, and ranks as the third most common cause of death overall. The Advanced Trauma Life Support (ATLS) program was developed to provide a systematic approach to the management of trauma patients, ensuring that life-threatening conditions are identified and treated promptly.

Mechanisms of Injury

In trauma, injuries can be classified based on their mechanisms:

Overt Mechanisms

1. Penetrating Trauma: Injuries caused by objects that penetrate the skin and underlying tissues.
2. Blunt Trauma: Injuries resulting from impact without penetration, such as collisions or falls.
3. Thermal Trauma: Injuries caused by heat, including burns.
4. Blast Injury: Injuries resulting from explosions, which can cause a combination of blunt and penetrating injuries.

Covert Mechanisms

1. Blunt Trauma: Often results in internal injuries that may not be immediately apparent.
2. Penetrating Trauma: Can include knife wounds and other sharp objects.
3. Penetrating Knife: Specific injuries from stabbing.
4. Gunshot Injury: Injuries caused by firearms, which can have extensive internal damage.

The track of penetrating injuries can often be identified by the anatomy involved, helping to determine which organs may be injured.

Steps in ATLS

The ATLS protocol consists of a systematic approach to trauma management, divided into two main surveys:

1. Primary Survey

• Objective: Identify and treat life-threatening conditions.
• Components:
  • A - Airway: Ensure the airway is patent. In patients with a Glasgow Coma Scale (GCS) of 8 or less, immediate intubation is necessary. Maintain cervical spine stability.
  • B - Breathing: Assess ventilation and oxygenation. Administer high-flow oxygen via a reservoir mask. Identify and treat conditions such as tension pneumothorax, flail chest, massive hemothorax, and open pneumothorax.
  • C - Circulation: Evaluate circulation based on:
    • Conscious level (indicates cerebral perfusion)
    • Skin color
    • Rapid, thready pulse (more reliable than blood pressure)
  • D - Disability: Assess neurological status using the Glasgow Coma Scale (GCS).
  • E - Exposure: Fully expose the patient to assess for injuries on the front and back.

2. Secondary Survey

• Objective: Conduct a thorough head-to-toe examination to identify all injuries.
• Components:
  • AMPLE: A mnemonic to gather important patient history:
    • A - Allergy: Any known allergies.
    • M - Medications: Current medications the patient is taking.
    • P - Past Medical History: Relevant medical history.
    • L - Last Meal: When the patient last ate.
    • E - Events of Incident: Details about the mechanism of injury.

Triage

Triage is the process of sorting patients based on the severity of their condition. The term "triage" comes from the French word meaning "to sort." In trauma settings, patients are categorized using a color-coded system:

• Red: First priority (critical patients, e.g., tension pneumothorax).
• Yellow: Second priority (urgent cases, e.g., pelvic fracture).
• Green: Third priority (minor injuries, e.g., simple fracture).
• Black: Zero priority (patients who are dead or unsalvageable).

Blunt Trauma

• Common Causes: The most frequent cause of blunt trauma is road traffic accidents.
• Seat Belt Use: Wearing seat belts significantly reduces mortality rates:
  • Front row occupants: 45% reduction in death rate.
  • Rear seat belt use: 80% reduction in death rate for front seat occupants.
• Seat Belt Injuries: Marks on the thorax indicate a fourfold increase in thoracic injuries, while abdominal marks indicate a threefold increase in abdominal injuries.

Radiographs in Trauma

Key radiographic views to obtain in trauma cases include:

1. Lateral cervical spine
2. Anteroposterior chest
3. Anteroposterior pelvis

Sinus

It is a tubular track lined by granulation tissue and open at one end which is at the surface,

eg. Tuberculous Sinus

Fistula

A tubular track lined by granulation tissue and open at both ends.at least one of which communicates with a hollow viscus. it can be internal or external.

Causes

1. Inadequate drainage

• Abscess bursting at the non dependent part
• Incision at the non-dependent part.
• Narrow outer opening leading to collection of exudates in the cavity.

2. Presence of foreign body like sequestrum or slough.

3. Persistence of infection.

4. When the track is lined by epithelium

5. Specific causes, TB., Syphilis, etc.

6. Marked fibrosis of the wall with obliteration of blood vessels.

7. Poor general condition causing delayed healing.

Treatment

1. control of specific infection,

2. Thorough excision of track to open up the cavity. Removal of foreign body and scraping of the epithelium

3. Through Scrapping of the wall to expose healthy tissue

4. Wound laid open and allowed to heal from the bottom leaving no pocket,

Intubation

Intubation is a critical procedure in airway management, and the choice of technique—oral intubation, nasal intubation, or tracheostomy—depends on the clinical situation, patient anatomy, and specific indications or contraindications. 

Indications for Each Intubation Technique

1. Oral Intubation

Oral intubation is often the preferred method in emergency situations and when nasal intubation is contraindicated. Indications include:

• Emergent Intubation: Situations such as cardiopulmonary resuscitation (CPR), unconsciousness, or apnea.
• Oral or Mandibular Trauma: When there is significant trauma to the oral cavity or mandible that may complicate nasal access.
• Cervical Spine Conditions: Conditions such as ankylosis, arthritis, or trauma that may limit neck movement.
• Gagging and Vomiting: In patients who are unable to protect their airway due to these conditions.
• Agitation: In cases where the patient is agitated and requires sedation and airway protection.

2. Nasal Intubation

Nasal intubation is indicated in specific situations where oral intubation may be difficult or impossible. Indications include:

• Nasal Obstruction: When there is a blockage in the oral route.
• Paranasal Disease: Conditions affecting the nasal passages that may necessitate nasal access.
• Awake Intubation: In cases where the patient is cooperative and can tolerate the procedure.
• Short (Bull) Neck: In patients with anatomical challenges that make oral intubation difficult.

3. Tracheostomy

Tracheostomy is indicated for long-term airway management or when other methods are not feasible. Indications include:

• Inability to Insert Translational Tube: When oral or nasal intubation fails or is not possible.
• Need for Long-Term Definitive Airway: In patients requiring prolonged mechanical ventilation or airway support.
• Obstruction Above Cricoid Cartilage: Conditions that obstruct the airway at or above the cricoid level.
• Complications of Translational Intubation: Such as glottic incompetence or inability to clear tracheobronchial secretions.
• Sleep Apnea Unresponsive to CPAP: In patients with severe obstructive sleep apnea who do not respond to continuous positive airway pressure (CPAP) therapy.
• Facial or Laryngeal Trauma: Structural contraindications to translaryngeal intubation.

Contraindications for Nasal Intubation

• Severe Fractures of the Midface: Nasal intubation is contraindicated due to the risk of further injury and complications.
• Nasal Fractures: Similar to midface fractures, nasal fractures can complicate nasal intubation and increase the risk of injury.
• Basilar Skull Fractures: The risk of entering the cranial cavity or causing cerebrospinal fluid (CSF) leaks makes nasal intubation unsafe in these cases.

• Contraindications for Oral Intubation

  1. Severe Facial or Oral Trauma:

     • Significant injuries to the face, jaw, or oral cavity may make oral intubation difficult or impossible and increase the risk of further injury.

  2. Obstruction of the Oral Cavity:

     • Conditions such as large tumors, severe swelling, or foreign bodies that obstruct the oral cavity can prevent successful intubation.

  3. Cervical Spine Instability:

     • Patients with unstable cervical spine injuries may be at risk of further injury if neck extension is required for intubation.

  4. Severe Maxillofacial Deformities:

     • Anatomical abnormalities that prevent proper visualization of the airway or access to the trachea.

  5. Inability to Open the Mouth:

     • Conditions such as trismus (lockjaw) or severe oral infections that limit mouth opening can hinder intubation.

  6. Severe Coagulopathy:

     • Patients with bleeding disorders may be at increased risk of bleeding during the procedure.

  7. Anticipated Difficult Airway:

     • In cases where the airway is expected to be difficult to manage, alternative methods may be preferred.

Contraindications for Tracheostomy

1. Severe Coagulopathy:

   • Patients with significant bleeding disorders may be at risk for excessive bleeding during the procedure.

2. Infection at the Site of Incision:

   • Active infections in the neck or tracheostomy site can increase the risk of complications and should be addressed before proceeding.

3. Anatomical Abnormalities:

   • Significant anatomical variations or deformities in the neck that may complicate the procedure or increase the risk of injury to surrounding structures.

4. Severe Respiratory Distress:

   • In some cases, if a patient is in severe respiratory distress, immediate intubation may be prioritized over tracheostomy.

5. Patient Refusal:

   • If the patient is conscious and refuses the procedure, it should not be performed unless there is an immediate life-threatening situation.

6. Inability to Maintain Ventilation:

   • If the patient cannot be adequately ventilated through other means, tracheostomy may be necessary, but it should be performed with caution.

7. Unstable Hemodynamics:

   • Patients with severe hemodynamic instability may not tolerate the procedure well, and alternative airway management strategies may be required.

Neuromuscular Blockers in Cardiac Anesthesia

In  patient on β-blockers, the choice of neuromuscular blockers (NMBs) is critical due to their potential cardiovascular effects. Here’s a detailed analysis of the implications of using fentanyl and various NMBs, particularly focusing on vecuronium and its effects.

Key Points on Fentanyl and β-Blockers

• Fentanyl:

  • Fentanyl is an opioid analgesic that can cause bradycardia due to its vagolytic activity. While it has minimal hemodynamic effects, the bradycardia it induces can be problematic, especially in patients already on β-blockers, which reduce heart rate and blood pressure.

• β-Blockers:

  • These medications reduce heart rate and blood pressure, which can compound the bradycardic effects of fentanyl. Therefore, careful consideration must be given to the choice of additional medications that may further depress cardiac function.

Vecuronium

• Effects:

  • Vecuronium is a non-depolarizing neuromuscular blocker that has minimal cardiovascular side effects when used alone. However, it can potentiate decreases in heart rate and cardiac index when administered after fentanyl.
  • The absence of positive chronotropic effects (unlike pancuronium) means that vecuronium does not counteract the bradycardia induced by fentanyl, leading to a higher risk of significant bradycardia and hypotension.

• Vagal Tone:

  • Vecuronium may enhance vagal tone, further predisposing patients to bradycardia. This is particularly concerning in patients on β-blockers, as the combination can lead to compounded cardiac depression.

Comparison with Other Neuromuscular Blockers

1. Pancuronium:

   • Vagolytic Action: Pancuronium has vagolytic properties that can help attenuate bradycardia and support blood pressure. It is often preferred in cardiac anesthesia for its more favorable hemodynamic profile compared to vecuronium.
   • Tachycardia: While it can induce tachycardia, this effect may be mitigated in patients on β-blockers, which can blunt the tachycardic response.

2. Atracurium:

   • Histamine Release: Atracurium can release histamine, leading to hemodynamic changes such as increased heart rate and decreased blood pressure. These effects can be minimized by slow administration of small doses.

3. Rocuronium:

   • Minimal Hemodynamic Effects: Rocuronium is generally associated with a lack of significant cardiovascular side effects, although occasional increases in heart rate have been noted.

4. Cis-Atracurium:

   • Cardiovascular Stability: Cis-atracurium does not have cardiovascular effects and does not release histamine, making it a safer option in terms of hemodynamic stability.

Tracheostomy

Tracheostomy is a surgical procedure that involves creating an opening in the trachea (windpipe) to facilitate breathing. This procedure is typically performed when there is a need for prolonged airway access, especially in cases where the upper airway is obstructed or compromised. The incision is usually made between the 2nd and 4th tracheal rings, as entry through the 1st ring can lead to complications such as tracheal stenosis.

Indications

Tracheostomy may be indicated in various clinical scenarios, including:

1. Acute Upper Airway Obstruction: Conditions such as severe allergic reactions, infections (e.g., epiglottitis), or trauma that obstruct the airway.
2. Major Surgery: Procedures involving the mouth, pharynx, or larynx that may compromise the airway.
3. Prolonged Mechanical Ventilation: Patients requiring artificial ventilation for an extended period, such as those with respiratory failure.
4. Unconscious Patients: Situations involving head injuries, tetanus, or bulbar poliomyelitis where airway protection is necessary.

Procedure

Technique

• Incision: A horizontal incision is made in the skin over the trachea, typically between the 2nd and 4th tracheal rings.
• Dissection: The subcutaneous tissue and muscles are dissected to expose the trachea.
• Tracheal Entry: An incision is made in the trachea, and a tracheostomy tube is inserted to maintain the airway.

Complications of Tracheostomy

Tracheostomy can be associated with several complications, which can be categorized into intraoperative, early postoperative, and late postoperative complications.

1. Intraoperative Complications

• Hemorrhage: Bleeding can occur during the procedure, particularly if major blood vessels are inadvertently injured.
• Injury to Paratracheal Structures:
  • Carotid Artery: Injury can lead to significant hemorrhage and potential airway compromise.
  • Recurrent Laryngeal Nerve: Damage can result in vocal cord paralysis and hoarseness.
  • Esophagus: Injury can lead to tracheoesophageal fistula formation.
  • Trachea: Improper technique can cause tracheal injury.

2. Early Postoperative Complications

• Apnea: Temporary cessation of breathing may occur, especially in patients with pre-existing respiratory issues.
• Hemorrhage: Postoperative bleeding can occur, requiring surgical intervention.
• Subcutaneous Emphysema: Air can escape into the subcutaneous tissue, leading to swelling and discomfort.
• Pneumomediastinum and Pneumothorax: Air can enter the mediastinum or pleural space, leading to respiratory distress.
• Infection: Risk of infection at the incision site or within the tracheostomy tube.

3. Late Postoperative Complications

• Difficult Decannulation: Challenges in removing the tracheostomy tube due to airway swelling or other factors.
• Tracheocutaneous Fistula: An abnormal connection between the trachea and the skin, which may require surgical repair.
• Tracheoesophageal Fistula: An abnormal connection between the trachea and esophagus, leading to aspiration and feeding difficulties.
• Tracheoinnominate Arterial Fistula: A rare but life-threatening complication where the trachea erodes into the innominate artery, resulting in severe hemorrhage.
• Tracheal Stenosis: Narrowing of the trachea due to scar tissue formation, which can lead to breathing difficulties.

Cardiovascular Effects of Sevoflurane, Halothane, and Isoflurane

• Sevoflurane:

  • Maintains cardiac index and heart rate effectively.

  • Exhibits less hypotensive and negative inotropic effects compared to halothane.

  • Cardiac output is greater than that observed with halothane.

  • Recovery from sevoflurane anesthesia is smooth and comparable to isoflurane, with a shorter time to standing than halothane.

• Halothane:

  • Causes significant decreases in mean arterial pressure, ejection fraction, and cardiac index.

  • Heart rate remains at baseline levels, but overall cardiovascular function is depressed.

  • Recovery from halothane is less favorable compared to sevoflurane and isoflurane.

• Isoflurane:

  • Preserves cardiac index and ejection fraction better than halothane.

  • Increases heart rate while having less suppression of mean arterial pressure compared to halothane.

  • Cardiac output during isoflurane anesthesia is similar to that of sevoflurane, indicating a favorable cardiovascular profile.